- Report
- October 2023
- 112 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- July 2023
- 95 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- May 2022
- 113 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- October 2023
- 146 Pages
Global
From €3211EUR$3,528USD£2,727GBP
€3777EUR$4,150USD£3,208GBP
- Report
- August 2022
- 151 Pages
Global
From €3186EUR$3,500USD£2,706GBP
- Report
- May 2022
- 65 Pages
Global
From €3186EUR$3,500USD£2,706GBP
- Report
- April 2022
- 152 Pages
Global
From €3186EUR$3,500USD£2,706GBP
From €117EUR$129USD£100GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- February 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Book
- July 2020
- 580 Pages
- Report
- November 2021
- 527 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- November 2021
- 545 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- November 2021
- 802 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Report
- November 2021
- 1184 Pages
Global
From €5461EUR$6,000USD£4,638GBP
- Report
- November 2021
- 1165 Pages
Global
From €5461EUR$6,000USD£4,638GBP
- Report
- August 2022
- 322 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP

Epigenetics is a field of genomics that studies the regulation of gene expression without altering the underlying DNA sequence. It is a rapidly growing field of research that has the potential to revolutionize the understanding of gene regulation and its role in disease. Epigenetics is the study of how environmental factors, such as diet, lifestyle, and exposure to toxins, can affect gene expression. It is also used to study the effects of aging and the development of cancer.
Epigenetics has become an important tool in the diagnosis and treatment of many diseases, including cancer, diabetes, and neurological disorders. It is also being used to develop new therapies and treatments for a variety of diseases.
The epigenetics market is expected to grow significantly in the coming years, driven by the increasing demand for personalized medicine and the development of new technologies. Companies in the epigenetics market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Merck KGaA, and PerkinElmer. Show Less Read more